Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TDS Pharm Co's share price for the quarter that ended in Dec. 2024 was ₩13240. TDS Pharm Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 5 Mil. Therefore, TDS Pharm Co's market cap for the quarter that ended in Dec. 2024 was ₩70,026 Mil.
TDS Pharm Co's quarterly market cap
increased
from Mar. 2024 (₩0 Mil) to Sep. 2024 (₩107,631 Mil) but then
declined
from Sep. 2024 (₩107,631 Mil) to Dec. 2024 (₩70,026 Mil).
TDS Pharm Co's annual market cap
stayed the same
from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩0 Mil) but then
increased
from Dec. 2023 (₩0 Mil) to Dec. 2024 (₩70,026 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TDS Pharm Co's Enterprise Value for Today is ₩43,492 Mil.
TDS Pharm Co Market Cap Historical Data
The historical data trend for TDS Pharm Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of TDS Pharm Co's Market Cap
For the Drug Manufacturers - General subindustry, TDS Pharm Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TDS Pharm Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's Market Cap distribution charts can be found below:
* The bar in red indicates where TDS Pharm Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
TDS Pharm Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TDS Pharm Co (XKRX:464280) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
TDS Pharm Co Market Cap Related Terms
Thank you for viewing the detailed overview of TDS Pharm Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:464280 has been successfully added to your 